Case Studies
Cresco Labs Secures Conditional Medical Cannabis License in Texas
AUSTIN – Cresco Labs Inc. announced that the Texas Department ...
U.S. Hempcrete Market Set for Steady Rise to $10.6B by 2033
LOS ANGELES – The market for hempcrete, a lightweight composite ...
From $700 Million Unicorn to Fire-Sale Exit: What the Eaze–Vireo Deal Says About California Cannabis
LOS ANGELES- When Eaze first burst onto the scene, ...
Germany’s Medical Cannabis Imports Hit Record in Q2 2025, Sparking Debate Over Misuse
BERLIN – Germany’s medical Cannabis market continues to set records, with imports reaching 43.3 tons in the second quarter of 2025, according to data from the Federal Institute for Drugs and Medical Devices (BfArM). This ...
Cresco Labs Strengthens Financial Position with $325 Million Senior Secured Term Loan Refinancing
CHICAGO – Cresco Labs Inc. announced the closing of a significant refinancing transaction, marking a strategic move towards long-term balance sheet stability. The company successfully replaced its previous $360 million senior secured credit facility with ...
Planet 13 Reports Q2 2025 Financial Results
LAS VEGAS – Planet 13 Holdings Inc., a vertically integrated multi-state Cannabis operator, released its Q2 2025 financial results, reflecting a challenging quarter marked by market pressures and strategic adjustments. The company reported revenue of ...
Cannabis in Psychedelic Therapy: Potential and Precautions
LOS ANGELES- The integration of cannabis into psychedelic-assisted psychotherapy is gaining attention as a potential treatment for various mental health conditions, including post-traumatic stress disorder (PTSD), depression, and anxiety. This approach involves administering cannabis in ...
Cybin Partners with Thermo Fisher for U.S. Manufacturing
LOS ANGELES- Cybin Inc. a neuropsychiatry company, has announced a collaboration with Thermo Fisher Scientific to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin analog, for the ...
Rubicon Organics Appoints Glen Ibbott as Interim CFO
LOS ANGELES- Rubicon Organics Inc. a Canadian producer of certified organic cannabis products, has appointed Glen Ibbott as Interim Chief Financial Officer, effective May 15, 2025. This leadership change follows the departure of Janis Risbin ...
TILT Holdings Reports First Quarter 2025 Financial Results
LOS ANGELES- TILT Holdings Inc. announced its financial results for the first quarter ended March 31, 2025, reflecting a year-over-year revenue decline and continued strategic realignment towards its Jupiter inhalation technology business. Financial Performance The ...
Germany’s Medical Cannabis Imports Hit Record in Q2 2025, Sparking Debate Over Misuse
BERLIN – Germany’s medical Cannabis market continues to set records, with imports reaching 43.3 tons in the second quarter of 2025, according to data from the Federal Institute for Drugs and Medical Devices (BfArM). This ...
Cresco Labs Strengthens Financial Position with $325 Million Senior Secured Term Loan Refinancing
CHICAGO – Cresco Labs Inc. announced the closing of a significant refinancing transaction, marking a strategic move towards long-term balance sheet stability. The company successfully replaced its previous $360 million senior secured credit facility with ...
Planet 13 Reports Q2 2025 Financial Results
LAS VEGAS – Planet 13 Holdings Inc., a vertically integrated multi-state Cannabis operator, released its Q2 2025 financial results, reflecting a challenging quarter marked by market pressures and strategic adjustments. The company reported revenue of ...
